Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-09

FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Alvogen, Inc.)

View source ↗

Summary

FDA approved a Supplemental Application for Levothyroxine Sodium from Alvogen, Inc. to continue regulatory recognition of the drug under its existing indication…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)